Your email has been successfully added to our mailing list.

×
0.000504020710669265 0.000595660839881763 -0.000412380581456635 -0.00159797475314438 -0.000561295791427076 -0.00345941487777496 -0.00378015533001896 -0.00213063300419255
Stock impact report

4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript [Seeking Alpha]

Goldman Sachs Group, Inc. (The) (GS) 
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am Check Earnings Report
US:NYSE Investor Relations: goldmansachs.com/investor-relations
Company Research Source: Seeking Alpha
Company Participants Julian Pei David Kirn - Co-Founder, CEO & Director Conference Call Participants Jennifer Taylor-Cousar Felix Ratjen Jonathan Miller - Evercore ISI Institutional Equities, Research Division Ryan Mcelroy - Leerink Partners LLC, Research Division Huidong Wang - Barclays Bank PLC, Research Division Tommie Reerink - Goldman Sachs Group, Inc., Research Division Daniel Giraldo Perez - BofA Securities, Research Division Yuxi Dong - Jefferies LLC, Research Division Presentation Operator Hello, ladies and gentlemen. Thank you for standing by, and welcome to our investor webcast today. As a reminder, today's call is being recorded. With that, I will hand the call over to Julian Pei, Head of Investor Relations, who will make introductory comments. Julian Pei Good morning, and thank you for joining our webcast to discuss interim Phase I data from our AEROW trial in cystic fibrosis. Before we begin, I encourage everyone to visit our Investor R Show less Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GS alerts
Opt-in for
GS alerts

from News Quantified
Opt-in for
GS alerts

from News Quantified